
| Time | Topic | Speakers |
| 07:45 - 9:00 | Light Breakfast – Bayshore Ballroom Salon ABC | |
| 09:00 - 10:15 | An update on prognostic and predictive biomarkers in head & neck malignancies | |
| 10:15 - 10:30 | Refreshment Break - Bayshore Ballroom Salon ABC | |
| 10:30 - 11:05 | Medical Oncology: Population based comparison of weekly and q3 weekly cisplatin in locally advanced nasopharyngeal carcinoma The role of taxanes in HNSCC: What's the evidence?
Systemic therapy in HNSCC: An ASCO Update Medical oncology department update |
|
| 11:05 - 11:45 | Radiation Oncology/Functional Imaging:
PGY1 – Toxicity in Combined Modality Treatment of HNSCC: Cisplatin versus cetuximab PGY 4 – Outcomes in Salivary Tumors New Therapeutic options in HNSCC Functional Imaging in Head and Neck Cancer OaSIS – Head & Neck outcomes unit research tool PET/CT Update: H&N Cancer |
Dr. Don Wilson
Dr. Francois Benard |
| 11:45 - 12:30 | Otolaryngology/Oral Oncology: Dysguesia in Head & Neck patients Oral oncology department update Fluorescence Visualization Guided Surgery In Oral Cancer |
Miriam Rosin |
| 12:30 - 13:30 | Lunch - Bayshore Ballroom Salon ABC | |
| 13:30 - 14:30 | Business Meeting (closed) Discussion of research initiatives |
|